awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58694356-30BAD695-AEE8-4E2B-B5BE-231B49D80C04
Q58694356-30BAD695-AEE8-4E2B-B5BE-231B49D80C04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58694356-30BAD695-AEE8-4E2B-B5BE-231B49D80C04
Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
P2860
Q58694356-30BAD695-AEE8-4E2B-B5BE-231B49D80C04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58694356-30BAD695-AEE8-4E2B-B5BE-231B49D80C04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1461f6d8caf0f6bf30895edcee295bd43b7126b4
P2860
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.